SFX by Ex Libris Inc.

Title:	Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibiotic
Source:	Science [0036-8075] Rosen, H yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Tenover, Fred C. "Vancomycin-resistant staphylococci and enterococci: epidemiology and control." Current opinion in infectious diseases 18.4 (2005): 300-305.
description	2.	Palazzo, I C V V. "First Report of Vancomycin-Resistant Staphylococci Isolated from Healthy Carriers in Brazil." Journal of clinical microbiology 43.1 (2005): 179-185.
description	3.	Naimi, Timothy S S. "Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia." Clinical infectious diseases 36.12 (2003): 1609-12.
description	4.	PERSONNEL, CDCN. "National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004." American journal of infection control 32.8 (2005): 470-85.
description	5.	Kvirikadze, N. "Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia." Scandinavian journal of infectious diseases 38.4 (2006): 290-2.
description	6.	Gould, I M M. "The clinical significance of methicillin-resistant staphylococcus aureus." The Journal of hospital infection 61.4 (2005): 277-82.
description	7.	Foucault, C. "How to fight antimicrobial resistance." FEMS immunology and medical microbiology 49.2 (2007): 173-183.
description	8.	Menezes GA, Harish BN, Sujatha S, Vinothini K, Par, G A. "Emergence of vancomycin-intermediate Staphylococcus species in southern India." Journal of medical microbiology 57.7: 911-912.
description	9.	Solomon, S. "National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003." American journal of infection control 31.8 (2004): 481-98.
description	10.	Morris, A.. "The superbugs: Evolution, dissemination and fitness." Current opinion in microbiology 1.5 (1998): 524-529.
description	11.	Jernigan, J. "Drug-resistant 'superbugs' require more aggressive measures." Materials management in health care 15.12 (2007): 15-7.
description	12.	DeBaun, B.. "Evaluation of the Antimicrobial Properties of an Alcohol-free 2% Chlorhexidine Gluconate Solution." AORN journal 87.5 (2008): 925-933.
description	13.	Eleftheriadou, I. "Methicillin-resistant Staphylococcus aureus in diabetic foot infections." Drugs 70.14 (2010): 1785-97.
description	14.	Raad, I. "Intravascular-catheter-related infections." Lancet 351.9106 (1998): 893-898.
description	15.	Gould, I M M. "Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control." International journal of antimicrobial agents 28.5 (2006): 379-84.
description	16.	Jansen, W T M M. "Bacterial resistance: A sensitive issue - Complexity of the challenge and containment strategy in Europe." Drug resistance updates 9.3 (2006): 123-133.
description	17.	Sia, Adolf W G. "Prosthetic joint infections." Infectious disease clinics of North America 19.4: 885-914.
description	18.	Moise, Pamela A. "Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia." Clinical therapeutics 37.7 (2015): 1443-145300.
description	19.	Mutters, Nico T. "Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance." Deutsches Ärzteblatt international 110.43 (2013): 725-731.
description	20.	Aires de Sousa, M. "Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones." FEMS immunology and medical microbiology 40.2 (2004): 101-111.